133 citations
,
November 2018 in “Aging” This study identified Azithromycin and Roxithromycin as novel senolytic antibiotics that effectively target and reduce senescent human fibroblast cells.
18 citations
,
August 2011 in “Clinical Drug Investigation” This study found that a combination of low-dose isotretinoin and oral azithromycin pulse effectively treats severe acne with an acceptable side effect profile and relatively low relapse rates.
4 citations
,
October 2020 in “Research Square (Research Square)” This study reported that more sensitive, early diagnosis and treatment of COVID-19 with drug combinations significantly improved clinical outcomes in males with or without androgenetic alopecia, preventing severe progression.
1 citations
,
October 2020 in “Research Square (Research Square)” This study observed that males with androgenetic alopecia using dutasteride showed significantly improved COVID-19 outcomes, including shorter duration of symptoms and viral shedding, compared to those not using it and non-AGA males.
16 citations
,
November 2020 in “Research Square (Research Square)” In this study, early treatment with nitazoxanide, ivermectin, or hydroxychloroquine, combined with azithromycin, was associated with reduced hospitalizations, respiratory complications, and deaths in early-stage COVID-19 patients compared to untreated controls.
11 citations
,
November 2020 in “bioRxiv (Cold Spring Harbor Laboratory)” This study observed that early treatment with azithromycin and either nitazoxanide, ivermectin, or hydroxychloroquine in COVID-19 patients may reduce viral shedding, symptom duration, and respiratory complications compared to untreated patients.
1 citations
,
October 2018 in “Infectious diseases in clinical practice” This case report documents what may be the second reported instance of azithromycin-induced agranulocytosis, highlighted by a sudden drop to zero in absolute neutrophil count in a 67-year-old man.
26 citations
,
June 2020 in “The Journal of Allergy and Clinical Immunology In Practice” This case study highlights that even short-term use of hydroxychloroquine for COVID-19 can potentially lead to acute generalized exanthematous pustulosis as an adverse effect.
6 citations
,
October 2020 in “medRxiv (Cold Spring Harbor Laboratory)” This study found that early pharmacological treatment of COVID-19 in females, including those with hyperandrogenic conditions, significantly improved clinical outcomes, with spironolactone users experiencing milder symptoms and faster recovery.
4 citations
,
October 2020 in “Research Square (Research Square)” In this study, hydroxychloroquine, nitazoxanide, and ivermectin demonstrated similar efficacy for overall clinical outcomes in COVID-19 when administered early with azithromycin, vitamins, and supplements, with nitazoxanide showing the strongest antiviral activity and safety profile among the three.
3 citations
,
January 2019 in “Cureus” This review discusses confluent and reticulated papillomatosis in polycystic ovarian syndrome patients, noting successful treatment with azithromycin in one case, and suggests potential association with acanthosis nigricans; it reports no new results.
1 citations
,
August 2022 in “American Journal of Tropical Medicine and Hygiene” This case report describes a 29-year-old man who developed scalp abscesses due to Mycobacterium abscessus infection after receiving scalp injections for hair loss, successfully treated with antibiotics.
June 2024 in “Archives of dermatological research” This study observed that patients with post-COVID telogen effluvium had lower serum ferritin levels than controls, but the levels were not indicative of nonanemic iron deficiency.
April 2024 in “REVISTA INTERDISCIPLINAR CIÊNCIAS MÉDICAS” In this study, 41% of participants reported experiencing alopecia post-COVID-19, with notable associations found between the condition and female sex, azithromycin use, and symptoms like fatigue and post-infection skin irritation.
March 2024 in “Faculty of 1000 Research Ltd” In this study, researchers at Jawaharlal Nehru Medical College are comparing the effectiveness and side effects of Adapalene gel (0.1%) and Tazarotene gel (0.05%) in acne treatment among patients aged 12-35, with assessments every 4, 8, and 12 weeks. Results are not reported yet.
This study reports an increase in the frequency and variety of skin conditions associated with COVID-19, noting that milder cases often present with pernio-like lesions, while severe cases may involve livedo racemosa, retiform purpura, and acral ischemia.
In this laboratory study, researchers developed and tested two in vitro models to simulate atopic dermatitis using HaCaT cells, finding that azithromycin displayed epithelial-strengthening properties in one model, potentially offering insights for future research on skin disease interventions.
April 2021 in “Bioscientia Medicina Journal of Biomedicine and Translational Research” This report describes a severe COVID-19 case in a patient with SLE and nephritis, where hydroxychloroquine improved outcomes after regular use.
April 2021 in “Bioscientia Medicina Journal of Biomedicine and Translational Research” This case report describes a patient with SLE and COVID-19, where hydroxychloroquine showed a favorable impact on the virus when taken regularly, leading to clinical improvement and discharge after 24 days.
5 citations
,
June 2022 in “Journal of Oncology” This study found that resistance to azithromycin in multiple myeloma cells was associated with activation of the Hedgehog signaling pathway and suggests that targeting this pathway could help improve drug resistance.
October 2023 in “Journal der Deutschen Dermatologischen Gesellschaft” In this study, a case of rosacea fulminans during pregnancy was successfully treated with a combination of oral azithromycin and prednisone, highlighting this treatment approach for managing similar cases.
40 citations
,
August 2018 in “Journal of the American Academy of Dermatology” This study reported that a 10-week course of clindamycin and rifampicin was commonly used for treating folliculitis decalvans but the evidence on its efficacy remains inconclusive due to the low quality of available studies.
18 citations
,
February 2023 in “Journal of Clinical Medicine” This study reported that neuropathic pain is prevalent in 6.7% of hospitalized COVID-19 patients during the acute phase and 34.3% of long COVID patients, highlighting the need for additional research.
9 citations
,
June 2022 in “Microorganisms” This review outlines the urgent need for effective therapeutic interventions against coronaviruses, as current vaccines are challenged by virus mutations, and emphasizes developing safe, affordable, and broad-spectrum antivirals for both human and porcine coronaviruses.
1 citations
,
April 2018 in “Infectious diseases in clinical practice” This case study describes an 85-year-old man's intermittent fever being ultimately diagnosed as Babesia infection after considering his travel history and diagnosing splenic infarcts, highlighting the importance of thorough patient history for accurate diagnosis.
2 citations
,
July 2021 in “Dermatologic Therapy” This case study reports a 58-year-old woman experiencing pressure-induced alopecia with concomitant acute telogen effluvium after severe COVID-19, suggesting a potential link between prolonged hospitalization and hair loss.
January 2010 in “Actas Dermo-Sifiliográficas” A woman was allergic to quinine in her anti-hair loss lotion.
116 citations
,
December 2017 in “International Journal of Women's Dermatology” This review discusses various treatment options for adult female acne, highlighting the need for tailored approaches due to individual patient needs and reports no clinical outcomes.
44 citations
,
January 2021 in “Dermatologic Therapy” This study suggests that COVID-19 infection may trigger telogen effluvium, a condition of hair shedding, though medication side effects and pandemic-related stress cannot be excluded as contributing factors.
35 citations
,
February 2012 in “The New England Journal of Medicine” Early diagnosis and treatment of TPP can prevent complications.